OCT Study of the MGuard Prime Stent in Patients With Heart Attacks — MASTER-OCT  

ST Segment Elevated Myocardial Infarction Clinical Trial

Official title: OCT Study of the MGuard Prime Embolic Protection Stent in Patients With Acute ST-segment Elevation Myocardial Infarction

Status Withdrawn

Clinical Trial Summary

The objective is to demonstrate that the Flow Area within a blocked coronary vessel as assessed by OCT is greater with the MGuard Prime stent compared to non-mesh control stent (BMS/DES) in subjects undergoing primary PCI for ST-segment elevation MI. The study hypothesis is that end of procedure flow area is greater with the MGuard Prime compared with stenting with a non-mesh DES or BMS.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Infarction
• Myocardial Infarction
• ST Segment Elevated Myocardial Infarction

• NCT number: NCT02222116
• Study type: Interventional
• Source: InspireMD
• Status: Withdrawn
• Phase: Phase 4
• Start date: October 2015
• Completion date: January 2016